Published November 2019 | Version v1
Journal article

Applying Data Science methods and tools to unveil healthcare use of lung cancer patients in a teaching hospital in Spain

  • 1. Universidad Politécnica de Madrid, Information Technologies Department, Puerta de Hierro-Majadahonda University Hospital (Spain)
  • 2. Puerta de Hierro-Majadahonda University Hospital, Medical Oncology Department (Spain)
  • 3. Universidad de Valencia, Facultad de Matemáticas (Spain)
  • 4. Puerta de Hierro-Majadahonda University Hospital, Admission and Clinical Documentation Department (Spain)
  • 5. Biomedical Sciences Research Institute Puerta de Hierro-Majadahonda University Hospital, Biostatistics Department (Spain)
  • 6. Universidad Politécnica de Madrid, Centro de Tecnología Biomédica (Spain)

Description

Purpose

Our primary goal was to study the use of outpatient attendances by lung cancer patients in Hospital Universitario Puerta de Hierro Majadahonda (HUPHM), Spain, by leveraging our Electronic Patient Record (EPR) and structured clinical registry of lung cancer cases as well as assessing current Data Science methods and tools.

Methods/patients

We applied the Cross-Industry Standard Process for Data Mining (CRISP-DM) to integrate and analyze activity data extracted from the EPR (9.3 million records) and clinical data of lung cancer patients from a previous registry that was curated into a new, structured database based on REDCap. We have described and quantified factors with an influence in outpatient care use from univariate and multivariate points of view (through Poisson and negative binomial regression).

Results

Three cycles of CRISP-DM were performed resulting in a curated database of 522 lung cancer patients with 133 variables which generated 43,197 outpatient visits and tests, 1538 ER visits and 753 inpatient admissions. Stage and ECOG-PS at diagnosis and Charlson Comorbidity Index were major contributors to healthcare use. We also found that the patients' pattern of healthcare use (even before diagnosis), the existence of a history of cancer in first-grade relatives, smoking habits, or even age at diagnosis, could play a relevant role.

Conclusions

Integrating activity data from EPR and clinical structured data from lung cancer patients and applying CRISP-DM has allowed us to describe healthcare use in connection with clinical variables that could be used to plan resources and improve quality of care.

Additional details

Identifiers

Publishing Information

Journal Title
Clinical and Translational Oncology (Print)
Journal Volume
21
Journal Issue
11
Journal Page Range
p. 1472-1481
ISSN
1699-048X

INIS

Country of Publication
Spain
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
54103234
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
DIAGNOSIS; EDUCATION; HOSPITALS; INDUSTRY; LUNGS; MINING; NEOPLASMS; PATIENTS; TOBACCO SMOKES
Descriptors DEC
AEROSOLS; BODY; BUILDINGS; COLLOIDS; DISEASES; DISPERSIONS; MEDICAL ESTABLISHMENTS; ORGANS; RESIDUES; RESPIRATORY SYSTEM; SMOKES; SOLS

Optional Information

Copyright
Copyright (c) 2019 Federaci#Latin Small Letter O With Acute#n de Sociedades Espa#Latin Small Letter N With Tilde#olas de Oncolog#Latin Small Letter I With Acute#a (FESEO)